Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

VS Tardelli, A Bisaga, FB Arcadepani, G Gerra… - …, 2020 - Springer
Rationale Agonist-based pharmacologic intervention is an accepted approach in treatment
of opioid and tobacco use disorders. Objectives We conducted a systematic review and …

Expanding the continuum of substance use disorder treatment: Nonabstinence approaches

CE Paquette, SB Daughters, K Witkiewitz - Clinical Psychology Review, 2022 - Elsevier
Only a small minority of people with substance use disorders (SUDs) receive treatment. A
focus on abstinence is pervasive in SUD treatment, defining success in both research and …

Personalizing the treatment of substance use disorders

ND Volkow - American Journal of Psychiatry, 2020 - Am Psychiatric Assoc
The opioid crisis in the United States has brought drug addiction to the forefront of the public
mind and to the attention of health care personnel, organizations, and agencies. The …

Contingency management for treatment attendance: a meta-analysis

RA Pfund, MK Ginley, CJ Rash, K Zajac - Journal of Substance Abuse …, 2022 - Elsevier
Background Treatment providers have applied contingency management (CM) treatment, an
intervention that often rewards individuals for drug abstinence (ie, ABS CM), to treatment …

Contingency management for drug use disorders: Meta-analysis and application of Tolin's criteria.

RA Pfund, MK Ginley, CL Boness, CJ Rash… - … Science and Practice, 2022 - psycnet.apa.org
Several professional organizations and federal agencies recommend contingency
management (CM) as an empirically supported treatment for drug use disorder. However …

Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials

M Amin‐Esmaeili, M Farokhnia, R Susukida… - …, 2024 - Wiley Online Library
Background and aims Total abstinence has historically been the goal of treatment for
substance use disorders; however, there is a growing recognition of the health benefits …

Neural classification of internet gaming disorder and prediction of treatment response using a cue-reactivity fMRI task in young men

ZL Wang, MN Potenza, KR Song, XY Fang, L Liu… - Journal of psychiatric …, 2022 - Elsevier
Background Neural mechanisms underlying internet gaming disorder (IGD) are important for
diagnostic considerations and treatment development. However, neurobiological …

Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use

LV Panlilio, SW Stull, JW Bertz, AJ Burgess-Hull… - …, 2021 - Springer
Rationale Given that many patients being treated for opioid-use disorder continue to use
drugs, identifying clusters of patients who share similar patterns of use might provide insight …

Neuropsychoimaging measures as alternatives to drug use outcomes in clinical trials for addiction

RZ Goldstein - JAMA psychiatry, 2022 - jamanetwork.com
Cognitive impairments in people with substance use disorders have been reliably
documented, generalizable across multiple domains and substance types. 1 Specific …

Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder.

BJ Sherman, MJ Sofis, JT Borodovsky… - … of addictive behaviors, 2022 - psycnet.apa.org
Objective: Abstinence is rarely achieved in clinical trials for cannabis use disorder (CUD).
Cannabis reduction is associated with functional improvement, but reduction endpoints have …